FORA Capital’s Axsome Therapeutics AXSM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-7,633
| Closed | -$890K | – | 511 |
|
|
2025
Q1 | $890K | Buy |
+7,633
| New | +$890K | 0.09% | 249 |
|
|
2024
Q4 | – | Sell |
-11,058
| Closed | -$994K | – | 394 |
|
|
2024
Q3 | $994K | Buy |
+11,058
| New | +$994K | 0.12% | 214 |
|
|
2024
Q1 | – | Sell |
-8,907
| Closed | -$709K | – | 408 |
|
|
2023
Q4 | $709K | Buy |
+8,907
| New | +$709K | 0.06% | 291 |
|
|
2022
Q4 | – | Sell |
-4,505
| Closed | -$201K | – | 464 |
|
|
2022
Q3 | $201K | Sell |
4,505
-11,713
| -72% | -$523K | 0.04% | 384 |
|
|
2022
Q2 | $621K | Buy |
16,218
+7,476
| +86% | +$286K | 0.12% | 209 |
|
|
2022
Q1 | $350K | Buy |
+8,742
| New | +$350K | 0.06% | 354 |
|
|
2021
Q3 | – | Sell |
-786
| Closed | -$53K | – | 393 |
|
|
2021
Q2 | $53K | Buy |
+786
| New | +$53K | 0.01% | 699 |
|
|
2021
Q1 | – | Sell |
-5,237
| Closed | -$427K | – | 776 |
|
|
2020
Q4 | $427K | Buy |
5,237
+4,925
| +1,579% | +$402K | 0.07% | 319 |
|
|
2020
Q3 | $22K | Sell |
312
-6,193
| -95% | -$437K | 0.01% | 571 |
|
|
2020
Q2 | $535K | Buy |
+6,505
| New | +$535K | 0.18% | 145 |
|